• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

乳腺转移性原发性血管肉瘤：我们能用节拍疗法制服它吗？

Metastatic Primary Angiosarcoma of the Breast: Can We Tame It the Metronomic Way.

作者信息

Pramanik Raja, Gogia Ajay, Malik Prabhat Singh, Gogi Ramana

机构信息

Department of Medical Oncology, BRA-IRCH, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Indian J Med Paediatr Oncol. 2017 Apr-Jun;38(2):228-231. doi: 10.4103/ijmpo.ijmpo_156_16.

DOI:10.4103/ijmpo.ijmpo_156_16
PMID:28900339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5582568/
Abstract

Primary angiosarcoma of the breast is a highly aggressive but rare malignant neoplasm. Palliative chemotherapy with different agents and combinations has been tried in the metastatic setting with poor results. We present the case of a young woman with this disease describing her aggressive course. We used a metronomic combination of oral drugs due to her poor general condition and achieved disease stabilization although not durable.

摘要

原发性乳腺血管肉瘤是一种侵袭性很强但罕见的恶性肿瘤。在转移性情况下，已经尝试了使用不同药物和联合方案的姑息化疗，但效果不佳。我们报告了一名患有这种疾病的年轻女性病例，描述了其侵袭性病程。由于她的一般状况较差，我们使用了口服药物的节拍式联合方案，虽然病情稳定效果不持久，但病情得到了控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6978/5582568/497137694b23/IJMPO-38-228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6978/5582568/497137694b23/IJMPO-38-228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6978/5582568/497137694b23/IJMPO-38-228-g001.jpg

相似文献

1
Metastatic Primary Angiosarcoma of the Breast: Can We Tame It the Metronomic Way.乳腺转移性原发性血管肉瘤：我们能用节拍疗法制服它吗？
Indian J Med Paediatr Oncol. 2017 Apr-Jun;38(2):228-231. doi: 10.4103/ijmpo.ijmpo_156_16.
2
Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.普萘洛尔与长春碱节拍化疗协同联合有效治疗晚期血管肉瘤：一项从 bench 到 bedside 的研究
EBioMedicine. 2016 Apr;6:87-95. doi: 10.1016/j.ebiom.2016.02.026. Epub 2016 Feb 17.
3
Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.普萘洛尔与节拍化疗联合靶向治疗：复发性转移性血管肉瘤的持续完全缓解
Ecancermedicalscience. 2015 Jan 8;9:499. doi: 10.3332/ecancer.2015.499. eCollection 2015.
4
Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2- locally advanced breast cancer.新辅助治疗中节拍化疗：针对HER2阳性和HER2阴性局部晚期乳腺癌患者的两项平行可行性试验（TraQme和TAME）的结果
Braz J Med Biol Res. 2015 May;48(5):479-85. doi: 10.1590/1414-431X20144354. Epub 2015 Mar 6.
5
Primary Angiosarcoma of the Spleen: Rare Diagnosis with Atypical Clinical Course.脾脏原发性血管肉瘤：罕见诊断与非典型临床病程
Case Rep Oncol Med. 2016;2016:4905726. doi: 10.1155/2016/4905726. Epub 2016 Oct 27.
6
Chemotherapy for angiosarcoma of the breast: case report of 30-year survival and analysis of the literature.乳腺癌血管肉瘤的化疗：30年生存病例报告及文献分析
Cancer Invest. 1994;12(2):145-55. doi: 10.3109/07357909409024870.
7
Cyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation.环磷酰胺-甲氨蝶呤“小剂量持续”化疗用于转移性乳腺癌的姑息治疗：一项比较性药物经济学评价
Ann Oncol. 2005 Aug;16(8):1243-52. doi: 10.1093/annonc/mdi240. Epub 2005 May 19.
8
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.帕妥珠单抗和曲妥珠单抗联合或不联合节拍化疗治疗人表皮生长因子受体 2（HER2）阳性转移性乳腺癌老年患者（EORTC 75111-10114）：老年特别工作组/乳腺癌研究组的一项开放标签、随机、2 期试验。
Lancet Oncol. 2018 Mar;19(3):323-336. doi: 10.1016/S1470-2045(18)30083-4. Epub 2018 Feb 9.
9
Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity.节拍化疗联合贝伐珠单抗和厄洛替尼治疗转移性 HER2 阴性乳腺癌患者的临床和生物学活性。
Clin Breast Cancer. 2012 Jun;12(3):207-14. doi: 10.1016/j.clbc.2012.03.008. Epub 2012 Apr 20.
10
Primary angiosarcoma of the breast: a case report.乳腺原发性血管肉瘤：一例报告
Int J Clin Exp Pathol. 2019 Feb 1;12(2):664-668. eCollection 2019.

引用本文的文献

1
Synchronous primary breast angiosarcoma with invasive ductal carcinoma.原发性乳腺血管肉瘤与浸润性导管癌并存。
Breast Dis. 2024;43(1):271-274. doi: 10.3233/BD-240003.
2
Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?血管肉瘤中的β-肾上腺素能受体阻断：该选择哪种β受体阻滞剂？
Front Oncol. 2022 Sep 15;12:940582. doi: 10.3389/fonc.2022.940582. eCollection 2022.
3
PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study.

本文引用的文献

1
Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.普萘洛尔与节拍化疗联合靶向治疗：复发性转移性血管肉瘤的持续完全缓解
Ecancermedicalscience. 2015 Jan 8;9:499. doi: 10.3332/ecancer.2015.499. eCollection 2015.
2
β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy.β-肾上腺素能系统，一个调控肿瘤进展和癌症治疗中药物靶点的幕后操纵者。
Semin Cancer Biol. 2013 Dec;23(6 Pt B):533-42. doi: 10.1016/j.semcancer.2013.08.009. Epub 2013 Sep 4.
3
β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.
PropAngio 研究方案：普萘洛尔单药治疗皮肤血管肉瘤的新辅助疗效试验——原理验证研究。
BMJ Open. 2020 Sep 10;10(9):e039449. doi: 10.1136/bmjopen-2020-039449.
4
The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer.β肾上腺素能受体拮抗剂普萘洛尔改变晚期乳腺癌的有丝分裂和凋亡信号。
Biomed J. 2019 Jun;42(3):155-165. doi: 10.1016/j.bj.2019.02.003. Epub 2019 Jul 25.
5
Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment.普萘洛尔单药治疗后原发性心脏血管肉瘤及转移结节消退
Oncoscience. 2018 Oct 11;5(9-10):264-268. doi: 10.18632/oncoscience.472. eCollection 2018 Sep.
6
Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.非选择性β受体阻滞剂可抑制血管肉瘤细胞的活力，并提高转移性血管肉瘤患者的无进展生存期和总生存期。
Oncoscience. 2018 Apr 29;5(3-4):109-119. doi: 10.18632/oncoscience.413. eCollection 2018 Mar.
β 受体阻滞剂通过直接的抗肿瘤和抗血管生成机制增加神经母细胞瘤对化疗的反应。
Br J Cancer. 2013 Jun 25;108(12):2485-94. doi: 10.1038/bjc.2013.205. Epub 2013 May 21.
4
Primary angiosarcoma of the breast: a case report.乳腺原发性血管肉瘤：一例报告。
Diagn Pathol. 2013 Apr 22;8:66. doi: 10.1186/1746-1596-8-66.
5
Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.针对β肾上腺素能受体的靶向治疗对血管内皮细胞瘤和血管肉瘤模型具有治疗效果。
PLoS One. 2013;8(3):e60021. doi: 10.1371/journal.pone.0060021. Epub 2013 Mar 28.
6
β-Adrenergic receptor expression in vascular tumors.血管肿瘤中的β-肾上腺素能受体表达。
Mod Pathol. 2012 Nov;25(11):1446-51. doi: 10.1038/modpathol.2012.108. Epub 2012 Jun 29.
7
High grade angiosarcoma arising in fibroadenoma.纤维腺瘤中发生的高级别血管肉瘤。
Diagn Pathol. 2011 Dec 20;6:125. doi: 10.1186/1746-1596-6-125.
8
Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment.普萘洛尔增强化疗药物的抗血管生成作用和抗肿瘤疗效：对乳腺癌治疗的意义。
Oncotarget. 2011 Oct;2(10):797-809. doi: 10.18632/oncotarget.343.
9
Long-term metronomic docetaxel chemotherapy for inoperative angiosarcoma of the scalp.头皮不可切除血管肉瘤的长期节拍性多西他赛化疗
J Dermatol. 2011 Apr;38(4):393-5. doi: 10.1111/j.1346-8138.2010.00988.x. Epub 2010 Sep 28.
10
Breast angiosarcoma that is not related to radiation exposure: a comprehensive review of the literature.非放射性暴露相关的乳腺血管肉瘤：文献综述。
Surg Today. 2011 Feb;41(2):163-8. doi: 10.1007/s00595-010-4341-x. Epub 2011 Jan 26.